News
- Author:
- Bruce Jancin
Publish date: September 25, 2020
Three agents that address major unmet needs move to phase 3.
News
- Author:
- Bruce Jancin
Publish date: September 25, 2020
“Enhanced responsiveness to food cues may be a mediating mechanism underlying overeating in ADHD,” said Elizabeth Martin, MSc.
News
- Author:
- Bruce Jancin
Publish date: September 25, 2020
The proportion of chats handled at the crisis hotline was 48% greater in the first half of 2020, compared with a year earlier.
News
- Author:
- Bruce Jancin
Publish date: September 23, 2020
Current guideline recommendations for long-term beta-blocker therapy after an acute MI may be outdated in the contemporary reperfusion era.
News
- Author:
- Bruce Jancin
Publish date: September 23, 2020
Dr. R. Haim Belmaker offers provocative results from a randomized, double-blind, controlled trial of a nonpharmacologic treatment.
News
- Author:
- Bruce Jancin
Publish date: September 17, 2020
The guidelines lift barriers to competitive sports participation by many with cardiovascular diseases.
News
- Author:
- Bruce Jancin
Publish date: September 16, 2020
“The take-home messages are that ECT does not lead to brain damage but rather to a profound gray matter increase,” said Dr. Alexander Sartorius.
News
- Author:
- Bruce Jancin
Publish date: September 15, 2020
The significant risk factors for NSSI in patients with ADHD were affective disorders, suicidality, and psychotic disorders in both sexes.
News
- Author:
- Bruce Jancin
Publish date: September 15, 2020
Individual lifetime total cancer risk ranges from 1% to 52%.
News
- Author:
- Bruce Jancin
Publish date: September 14, 2020
“Being able to see if an antidepressant works within 1 week would be a real breakthrough,” said Catherine Harmer, DPhil.
News
- Author:
- Bruce Jancin
Publish date: September 14, 2020
“This is an interesting hypothesis, for sure, that warrants further study to confirm whether it’s valid.” – Dr. Mark H. Drazner
News
- Author:
- Bruce Jancin
Publish date: September 2, 2020
Restrictive transfusion proves more effective and less costly than liberal transfusion.
News
- Author:
- Bruce Jancin
Publish date: September 1, 2020
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides
News
- Author:
- Bruce Jancin
Publish date: August 31, 2020
Study shows equally good rate control as with a beta-blocker, but with far fewer adverse events.
News
- Author:
- Bruce Jancin
Publish date: August 30, 2020
EAST-AFNET 4 trial reanimates rhythm-control strategy as superior for 5-year cardiovascular outcomes.
